Breelyn Wilky

15PUBLICATIONS
119CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 13, 2026
Immunotherapy in the Treatment of Soft Tissue Sarcoma Since SARC028: An NCDB Analysis.

|Apr 13, 2026
Desmoid Tumors-Biology-Driven Management and Treatment Selection.

Dyda Dao, Katarzyna Kozak, Anne Mailhot

|Mar 11, 2026
Engineering T Cells with a Tumor-Reactive Chimeric T-cell Receptor Reduces Exhaustion and Promotes Persistence to Elicit Enhanced Antitumor Responses.

Joey C Magno, Jitao Guo, Spencer C Hall

|Nov 17, 2025
Durable response with mutation-guided ALK inhibition in a patient with metastatic epithelioid inflammatory myofibroblastic sarcoma: A case report.

Sumra S Chaudhry, D Ross Camidge, Michael R Clay

|May 16, 2025
A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas.

Breelyn A Wilky, Katherine A Julian, Alessandra Maleddu

|Feb 10, 2025
Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers.

Eric P Winer, Laura A Levit, Ethan Basch

Pageof 3

Frequent Collaborators

2 joint publications

Anne Mailhot

2 joint publications

Eduardo Davila

2 joint publications

Anthony Elias

2 joint publications

Piotr Rutkowski